» Articles » PMID: 9034343

Oncogenic Potential of TAR RNA Binding Protein TRBP and Its Regulatory Interaction with RNA-dependent Protein Kinase PKR

Overview
Journal EMBO J
Date 1997 Feb 3
PMID 9034343
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

TAR RNA binding protein (TRBP) belongs to an RNA binding protein family that includes the double-stranded RNA-activated protein kinase (PKR), Drosophila Staufen and Xenopus xlrbpa. One member of this family, PKR, is a serine/threonine kinase which has anti-viral and anti-proliferative effects. In this study we show that TRBP is a cellular down-regulator of PKR function. Assaying expression from an infectious HIV-1 molecular clone, we found that PKR inhibited viral protein synthesis and that over-expression of TRBP effectively countered this inhibition. In intracellular and in cell-free assays we show that TRBP directly inhibits PKR autophosphorylation through an RNA binding-independent pathway. Biologically, TRBP serves a growth-promoting role; cells that overexpress TRBP exhibit transformed phenotypes. Our results demonstrate the oncogenic potential of TRBP and are consistent with the notion that intracellular PKR function contributes physiologically towards regulating cellular proliferation.

Citing Articles

Mutation in Prkra results in cerebellar abnormality and reduced eIF2α phosphorylation in a model of DYT-PRKRA.

Burnett S, Culver A, Simon T, Rowson T, Frederick K, Palmer K Dis Model Mech. 2024; 17(11).

PMID: 39512178 PMC: 11625895. DOI: 10.1242/dmm.050929.


Help or Hinder: Protein Host Factors That Impact HIV-1 Replication.

Moezpoor M, Stevenson M Viruses. 2024; 16(8).

PMID: 39205255 PMC: 11360189. DOI: 10.3390/v16081281.


Interferon-Stimulated Genes that Target Retrovirus Translation.

Jager N, Pohlmann S, Rodnina M, Ayyub S Viruses. 2024; 16(6).

PMID: 38932225 PMC: 11209297. DOI: 10.3390/v16060933.


A frameshift mutation in the murine gene causes dystonia and exhibits abnormal cerebellar development and reduced eIF2α phosphorylation.

Burnett S, Culver A, Simon T, Rowson T, Frederick K, Palmer K bioRxiv. 2024; .

PMID: 38895245 PMC: 11185611. DOI: 10.1101/2024.06.04.597421.


RNA-binding proteins and exoribonucleases modulating miRNA in cancer: the enemy within.

Seo Y, Rhim J, Kim J Exp Mol Med. 2024; 56(5):1080-1106.

PMID: 38689093 PMC: 11148060. DOI: 10.1038/s12276-024-01224-z.


References
1.
Edlin B, St Clair M, Pitha P, Whaling S, King D, Bitran J . In-vitro resistance to zidovudine and alpha-interferon in HIV-1 isolates from patients: correlations with treatment duration and response. Ann Intern Med. 1992; 117(6):457-60. DOI: 10.7326/0003-4819-117-6-457. View

2.
Yang Y, Reis L, Pavlovic J, Aguzzi A, Schafer R, Kumar A . Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 1995; 14(24):6095-106. PMC: 394734. DOI: 10.1002/j.1460-2075.1995.tb00300.x. View

3.
Koromilas A, Roy S, Barber G, Katze M, Sonenberg N . Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science. 1992; 257(5077):1685-9. DOI: 10.1126/science.1382315. View

4.
Davies M, Elroy-Stein O, Jagus R, Moss B, Kaufman R . The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J Virol. 1992; 66(4):1943-50. PMC: 288982. DOI: 10.1128/JVI.66.4.1943-1950.1992. View

5.
Edery I, Petryshyn R, Sonenberg N . Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: a novel translational control mechanism. Cell. 1989; 56(2):303-12. DOI: 10.1016/0092-8674(89)90904-5. View